KDELR1
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1, also known as KDELR1, is a protein which in humans is encoded by the KDELR1 gene.[1][2]
| View/Edit Human | View/Edit Mouse |
Function
Retention of resident soluble proteins in the lumen of the endoplasmic reticulum (ER) is achieved in both yeast and animal cells by their continual retrieval from the cis-Golgi or a pre-Golgi compartment. Sorting of these proteins is dependent on a C-terminal tetrapeptide signal, usually lys-asp-glu-leu (KDEL) in animal cells and his-asp-glu-leu (HDEL) in S. cerevisiae. This process is mediated by a receptor that recognizes and binds the tetrapeptide-containing protein and then returns it to the ER. In yeast, the sorting receptor is encoded by a single gene, ERD2, which is a seven-transmembrane protein. Unlike yeast, several human homologs of the ERD2 gene, constituting the KDEL receptor gene family, have been described. The protein encoded by this gene was the first member of the family to be identified, and it encodes a protein structurally and functionally similar to the yeast ERD2 gene product.[2] The KDEL receptor mediates the retrieval of misfolded proteins between the ER and the Golgi apparatus.[5] The KDEL receptor functions by binding to endoplasmic reticulum chaperones.[5] These chaperones are recognized by the KDEL receptor in downstream compartments of the ER. Once bound, they are packaged into coat protein complex I vesicles for retrograde transport to the ER.[6] In vitro studies in yeast have revealed that this receptor regulates membrane transport in the early stages of the secretory pathway from ER to the Golgi.[6] An error or mutation in the KDEL receptor disturbs the ER quality control and diseases associated with ER stress are observed.[7]
KDEL and dilated cardiomyopathy
KDEL receptors have been implicated in the development of dilated cardiomyopathy (DCM). To determine the relationship between KDEL receptor and dilated cardiomyopathy, transgenic mice with a point mutation (D193N) were made.[5] The mice expressing the transport mutant D193N gene grew normally until they reached adulthood. The mutant KDEL receptor did not function after 14 weeks of age, and these mice developed DCM. They were observed to have dilated heart chambers, as well as higher heart-to-body ratios with enlarged hearts, and the cardiac myocytes were larger in size.[5] No difference was observed in arterial blood pressure between wild-type and mutant mice, thus cardiomegaly was not attributed to hypertension.[5] Upon analysis, it was found that KDEL mutant mice had proliferation in their sarcoplasmic reticulum (SR) and a narrowing in the transverse tubule compared to the wild-type and controls. Moreover, aggregations of degenerative membrane proteins were observed in the expanded SR. This suggests that the mutant KDEL receptor leads to impaired recycling and quality control of the ER, which leads to aggregation of misfolded proteins in the ER. Furthermore, KDEL D193N transgenic mice had defects in the L-type Ca++ channel current in ventricular myocytes.[5] The basal current of these channels was significantly lower than the controls. L-type channels expression was lower in the plasma membrane of the KDEL D193N heart cells due to the narrowing of transverse tubules.[5] BiP, a chaperone protein, was unevenly distributed and synthesized in larger proportion in the transgenic mutant mice, which suggests that there was an increase in concentration of misfolded proteins.[5] They also observed aggregates of the ubiquitin-proteasome system (a degradation system); this suggests that there was saturation of the system due to the high levels of misfolded proteins that lead to impaired ER quality control.[5] The researchers concluded that hyperubiquitination and saturation of the proteasome system results due to the accumulation of misfolded protein, which induces stress.[5] The accumulation of misfolded proteins induced by ER stress has also been observed in human DCM.[8] A murine DCM study found an increase in apoptosis due to the high levels of CHOP expression. CHOP is a transcription factor that is elevated during ER stress and causes apoptosis of cells during the process of an unfolded protein response.[9] Increase pressure load/mechanical stress in KDEL D193N mice caused an even greater synthesis of BiP, CHOP and other proteins that are biomarkers of cellular stress and ER stress as the capacity of the ER to deal with this is very limited.[5]
Interactions
KDELR1 has been shown to interact with ARFGAP1.[10][11]
See also
References
- ↑ Lewis MJ, Pelham HR (November 1990). "A human homologue of the yeast HDEL receptor". Nature. 348 (6297): 162–3. doi:10.1038/348162a0. PMID 2172835.
- 1 2 "Entrez Gene: KDELR1 KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1".
- ↑ "Human PubMed Reference:".
- ↑ "Mouse PubMed Reference:".
- 1 2 3 4 5 6 7 8 9 10 11 Hamada H, Suzuki M, Yuasa S, Mimura N, Shinozuka N, Takada Y, Suzuki M, Nishino T, Nakaya H, Koseki H, Aoe T (Sep 2004). "Dilated cardiomyopathy caused by aberrant endoplasmic reticulum quality control in mutant KDEL receptor transgenic mice". Molecular and Cellular Biology. 24 (18): 8007–17. doi:10.1128/MCB.24.18.8007-8017.2004. PMID 15340063.
- 1 2 Semenza, J.C.; Hardwick G; Dean N; Pelham H.R (1990). "ERD2, a yeast gene required for the receptor-mediated retrieval of luminal ER proteins from the secretory pathway". Cell. 61 (7): 1349–57. doi:10.1016/0092-8674(90)90698-e.
- ↑ Townsley, M. F; Wilson W.D; Pelham R.B.H (1993). "Mutational analysis of the human KDEL receptor: distinct structural requirements for Golgi retention, ligand binding and retrograde transport". The EMBO Journal. 12 (7): 2821–29.
- ↑ Weekes J, Morrison K, Mullen A, Wait R, Barton P, Dunn MJ (2003). "Hyperubiquitination of proteins in dilated cardiomyopathy". Proteomics. 3 (2): 208–16. doi:10.1002/pmic.200390029. PMID 12601813.
- ↑ Zinszer, H; Kuroda M; Wang X; Batchvarova N; et al. (1998). "CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum". Genes Dev. 12 (7): 982–95. doi:10.1101/gad.12.7.982.
- ↑ Aoe T, Cukierman E, Lee A, Cassel D, Peters PJ, Hsu VW (Dec 1997). "The KDEL receptor, ERD2, regulates intracellular traffic by recruiting a GTPase-activating protein for ARF1". EMBO J. 16 (24): 7305–16. doi:10.1093/emboj/16.24.7305. PMC 1170331
. PMID 9405360. - ↑ Majoul I, Straub M, Hell SW, Duden R, Söling HD (Jul 2001). "KDEL-cargo regulates interactions between proteins involved in COPI vesicle traffic: measurements in living cells using FRET". Dev. Cell. 1 (1): 139–53. doi:10.1016/S1534-5807(01)00004-1. PMID 11703931.
Further reading
- Pelham HR (1997). "The dynamic organisation of the secretory pathway.". Cell Struct. Funct. 21 (5): 413–9. doi:10.1247/csf.21.413. PMID 9118249.
- Lewis MJ, Pelham HR (1992). "Ligand-induced redistribution of a human KDEL receptor from the Golgi complex to the endoplasmic reticulum.". Cell. 68 (2): 353–64. doi:10.1016/0092-8674(92)90476-S. PMID 1310258.
- Lewis MJ, Pelham HR (1990). "A human homologue of the yeast HDEL receptor.". Nature. 348 (6297): 162–3. doi:10.1038/348162a0. PMID 2172835.
- Townsley FM, Wilson DW, Pelham HR (1993). "Mutational analysis of the human KDEL receptor: distinct structural requirements for Golgi retention, ligand binding and retrograde transport.". EMBO J. 12 (7): 2821–9. PMC 413532. PMID 8392934.
- Aoe T, Cukierman E, Lee A, Cassel D, Peters PJ, Hsu VW (1998). "The KDEL receptor, ERD2, regulates intracellular traffic by recruiting a GTPase-activating protein for ARF1.". EMBO J. 16 (24): 7305–16. doi:10.1093/emboj/16.24.7305. PMC 1170331. PMID 9405360.
- Smith JS, Tachibana I, Pohl U, Lee HK, Thanarajasingam U, Portier BP, Ueki K, Ramaswamy S, Billings SJ, Mohrenweiser HW, Louis DN, Jenkins RB (2000). "A transcript map of the chromosome 19q-arm glioma tumor suppressor region.". Genomics. 64 (1): 44–50. doi:10.1006/geno.1999.6101. PMID 10708517.
- Majoul I, Straub M, Hell SW, Duden R, Söling HD (2001). "KDEL-cargo regulates interactions between proteins involved in COPI vesicle traffic: measurements in living cells using FRET.". Dev. Cell. 1 (1): 139–53. doi:10.1016/S1534-5807(01)00004-1. PMID 11703931.
- Matsuda A, Suzuki Y, Honda G, Muramatsu S, Matsuzaki O, Nagano Y, Doi T, Shimotohno K, Harada T, Nishida E, Hayashi H, Sugano S (2003). "Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways.". Oncogene. 22 (21): 3307–18. doi:10.1038/sj.onc.1206406. PMID 12761501.
- Yamamoto K, Hamada H, Shinkai H, Kohno Y, Koseki H, Aoe T (2003). "The KDEL receptor modulates the endoplasmic reticulum stress response through mitogen-activated protein kinase signaling cascades.". J. Biol. Chem. 278 (36): 34525–32. doi:10.1074/jbc.M304188200. PMID 12821650.
- Bard F, Mazelin L, Péchoux-Longin C, Malhotra V, Jurdic P (2004). "Src regulates Golgi structure and KDEL receptor-dependent retrograde transport to the endoplasmic reticulum.". J. Biol. Chem. 278 (47): 46601–6. doi:10.1074/jbc.M302221200. PMID 12975382.
- Breuza L, Halbeisen R, Jenö P, Otte S, Barlowe C, Hong W, Hauri HP (2004). "Proteomics of endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membranes from brefeldin A-treated HepG2 cells identifies ERGIC-32, a new cycling protein that interacts with human Erv46.". J. Biol. Chem. 279 (45): 47242–53. doi:10.1074/jbc.M406644200. PMID 15308636.
- Ewing RM, Chu P, Elisma F, Li H, Taylor P, Climie S, McBroom-Cerajewski L, Robinson MD, O'Connor L, Li M, Taylor R, Dharsee M, Ho Y, Heilbut A, Moore L, Zhang S, Ornatsky O, Bukhman YV, Ethier M, Sheng Y, Vasilescu J, Abu-Farha M, Lambert JP, Duewel HS, Stewart II, Kuehl B, Hogue K, Colwill K, Gladwish K, Muskat B, Kinach R, Adams SL, Moran MF, Morin GB, Topaloglou T, Figeys D (2007). "Large-scale mapping of human protein-protein interactions by mass spectrometry.". Mol. Syst. Biol. 3 (1): 89. doi:10.1038/msb4100134. PMC 1847948. PMID 17353931.